Lucas Pham-Van is a project manager at Amoneta Diagnostics.

He has notably focused on neurodegenerative diseases, enhancing comprehension and management strategies for conditions like Multiple Sclerosis and Alzheimer diseases.

His work emphasizes the critical need for innovative biomarkers and molecular characterizations to address the heterogeneity of neurodegenerative diseases.

Lucas’s dedication to this field is evident in his contributions to scientific projects, development of new drug targets, and the implementation of advanced diagnostic tools. His efforts not only have advanced the scientific understanding of these complex conditions but also aim to improve patient outcomes through targeted therapeutic interventions